Clinical trial
Double-blind, Placebo-controlled Study of Levetiracetam in Adults With POS
NCT00152373 · UCB Pharma, Industry · Completed
Key facts
| NCT number | NCT00152373 |
|---|---|
| Title | Double-blind, Placebo-controlled Study of Levetiracetam in Adults With POS |
| Official title | A Double-blind, Placebo-controlled, Randomized Study: 16-week Evaluation of the Efficacy and Safety of Levetiracetam (LEV) as add-on Therapy in Adults and Adolescents Older Than 16 Years Suffering From Partial Seizures. |
| Lead sponsor | UCB Pharma, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Epilepsy, Partial |
| Intervention type | Drug |
| Interventions | Levetiracetam |
| Enrollment | 192 |
| Start date | Jul 1, 2004 |
| Primary completion | May 1, 2005 |
| Completion | May 1, 2005 |
| First posted | Sep 9, 2005 |
| Last update posted | Dec 3, 2013 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: